Nabriva Therapeutics US, Inc.
Nabriva Therapeutics US, Inc.
Categories
Biotech Pharmaceutical
About
Nabriva Therapeutics is a biotechnology company focused on developing a new class of antibiotics, pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant pathogens. Nabriva's world class medicinal chemistry expertise has achieved an industry first with the development of intravenous and orally available pleuromutilins ideal for i.v. to oral switch therapy.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.